Loïc Lebellec

929 total citations
22 papers, 303 citations indexed

About

Loïc Lebellec is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Loïc Lebellec has authored 22 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in Loïc Lebellec's work include Sarcoma Diagnosis and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (7 papers) and Oral and Maxillofacial Pathology (5 papers). Loïc Lebellec is often cited by papers focused on Sarcoma Diagnosis and Treatment (13 papers), Bone Tumor Diagnosis and Treatments (7 papers) and Oral and Maxillofacial Pathology (5 papers). Loïc Lebellec collaborates with scholars based in France, United States and Taiwan. Loïc Lebellec's co-authors include Nicolas Penel, Emmanuelle Bompas, François Bertucci, Jean‐Yves Blay, Thomas Ryckewaert, Emmanuelle Tresch‐Bruneel, Axel Le Cesne, Christine Chevreau, Esma Saâda-Bouzid and Stéphanie Clisant and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Loïc Lebellec

22 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loïc Lebellec France 9 186 137 98 80 55 22 303
Atrayee Basu Mallick United States 9 155 0.8× 117 0.9× 104 1.1× 48 0.6× 31 0.6× 33 273
Jane Dancer United States 7 166 0.9× 67 0.5× 134 1.4× 27 0.3× 54 1.0× 7 300
Doha Itani United States 10 128 0.7× 123 0.9× 71 0.7× 37 0.5× 36 0.7× 21 302
Alexandra Meurgey France 10 156 0.8× 93 0.7× 63 0.6× 14 0.2× 18 0.3× 29 250
CH Carrasco United States 8 172 0.9× 92 0.7× 81 0.8× 53 0.7× 123 2.2× 11 315
Jingnan Shen China 13 301 1.6× 120 0.9× 121 1.2× 20 0.3× 183 3.3× 39 455
Tuğba Akın Telli Türkiye 10 140 0.8× 40 0.3× 201 2.1× 14 0.2× 99 1.8× 47 389
Stefano Lari Italy 6 271 1.5× 167 1.2× 89 0.9× 13 0.2× 106 1.9× 9 356
Nicolas de Saint Aubain Belgium 9 76 0.4× 69 0.5× 65 0.7× 9 0.1× 68 1.2× 30 239
Kesavan Sittampalam Singapore 9 215 1.2× 116 0.8× 129 1.3× 31 0.4× 28 0.5× 23 300

Countries citing papers authored by Loïc Lebellec

Since Specialization
Citations

This map shows the geographic impact of Loïc Lebellec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loïc Lebellec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loïc Lebellec more than expected).

Fields of papers citing papers by Loïc Lebellec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loïc Lebellec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loïc Lebellec. The network helps show where Loïc Lebellec may publish in the future.

Co-authorship network of co-authors of Loïc Lebellec

This figure shows the co-authorship network connecting the top 25 collaborators of Loïc Lebellec. A scholar is included among the top collaborators of Loïc Lebellec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loïc Lebellec. Loïc Lebellec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deley, Marie‐Cécile Le, Mehdi Brahmi, Emmanuelle Bompas, et al.. (2025). Relative Dose Intensity of Trabectedin and Outcome of Advanced L‐Sarcomas. Cancer Medicine. 14(16). e71131–e71131. 1 indexed citations
2.
3.
Fournier, Clémence, Éric Leblanc, Marie‐Cécile Le Deley, et al.. (2023). Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors. Cancers. 15(11). 2997–2997. 2 indexed citations
4.
Oh, Do‐Youn, Alain P. Algazi, Jaume Capdevila, et al.. (2023). Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study. Cancer. 129(8). 1195–1204. 31 indexed citations
5.
Delanoy, Nicolas, Marie‐Cécile Le Deley, Nicolas Penel, et al.. (2023). Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy. Clinical Genitourinary Cancer. 21(3). 349–356.e2. 3 indexed citations
6.
Penel, Nicolas, et al.. (2022). Novel treatment approaches for HER2 positive solid tumors (excluding breast cancer). Current Opinion in Oncology. 34(5). 570–574. 7 indexed citations
7.
Béhal, Hélène, Loïc Lebellec, Simon Baldacci, et al.. (2021). Does bevacizumab increase joint pain in patients with cancer? Results of the prospective observational BEVARTHRALGIA study. Cancer Chemotherapy and Pharmacology. 87(4). 533–541. 3 indexed citations
8.
Penel, Nicolas, Loïc Lebellec, Jean‐Yves Blay, & Y Robin. (2020). Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies. Critical Reviews in Oncology/Hematology. 150. 102960–102960. 1 indexed citations
9.
Lebellec, Loïc, et al.. (2020). Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials. Frontiers in Oncology. 10. 594445–594445. 13 indexed citations
10.
Lebellec, Loïc, et al.. (2020). Maintenance therapy and drug holiday in sarcoma patients: systematic review. Acta Oncologica. 59(9). 1084–1090. 7 indexed citations
11.
Pasquier, Dominique, et al.. (2019). Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases. Frontiers in Oncology. 9. 732–732. 17 indexed citations
12.
Lebellec, Loïc, Marie‐Cécile Le Deley, Kocéila Amroun, et al.. (2019). Prognostic value of the texture analysis parameters of the initial computed tomographic scan for response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer. Radiotherapy and Oncology. 135. 153–160. 24 indexed citations
13.
Lebellec, Loïc, François Bertucci, Emmanuelle Tresch‐Bruneel, et al.. (2018). Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial. BMC Cancer. 18(1). 963–963. 15 indexed citations
14.
Bretagne, Marie, et al.. (2017). Quels biomarqueurs d’avenir ? Le point de vue des internes en oncologie à l’issue du congrès de l’ESMO 2016. Bulletin du Cancer. 104(9). 744–751. 1 indexed citations
15.
16.
17.
Lebellec, Loïc, Axel Le Cesne, Nicolas Penel, et al.. (2016). Molecular targeted therapies (MTT) in advanced chordoma (AC) patients (pts).. Journal of Clinical Oncology. 34(15_suppl). 11020–11020. 1 indexed citations
18.
19.
Bompas, Emmanuelle, Axel Le Cesne, Emmanuelle Tresch‐Bruneel, et al.. (2015). Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO). Annals of Oncology. 26(10). 2168–2173. 82 indexed citations
20.
Lebellec, Loïc, Sébastien Aubert, Fahed Zaïri, et al.. (2015). Molecular targeted therapies in advanced or metastatic chordoma patients: Facts and hypotheses. Critical Reviews in Oncology/Hematology. 95(1). 125–131. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atrayee Basu Mallick Breakdown of academic impact, for papers by Jane Dancer Breakdown of academic impact, for papers by Doha Itani Breakdown of academic impact, for papers by Alexandra Meurgey Breakdown of academic impact, for papers by CH Carrasco Breakdown of academic impact, for papers by Jingnan Shen Breakdown of academic impact, for papers by Tuğba Akın Telli Breakdown of academic impact, for papers by Stefano Lari Breakdown of academic impact, for papers by Nicolas de Saint Aubain Breakdown of academic impact, for papers by Kesavan Sittampalam
Rankless by CCL
2026